Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 77

1.

EBV interferes with the sensitivity of Burkitt lymphoma Akata cells to etoposide.

Lima RT, Seca H, Soares P, Nascimento MS, Vasconcelos MH.

J Cell Biochem. 2011 Jan;112(1):200-10. doi: 10.1002/jcb.22920.

PMID:
21069730
3.

Differential regulation of Epstein-Barr virus (EBV) latent gene expression in Burkitt lymphoma cells infected with a recombinant EBV strain.

Trivedi P, Spinsanti P, Cuomo L, Volpe M, Takada K, Frati L, Faggioni A.

J Virol. 2001 May;75(10):4929-35.

4.

Epstein-Barr virus-mediated protection against etoposide-induced apoptosis in BJA-B B cell lymphoma cells: role of Bcl-2 and caspase proteins.

Blood A, Edwards CJ, Ishii HH, Pat BK, Bryson G, Sculley TB, Gobe GC.

Arch Virol. 2004 Feb;149(2):289-302. Epub 2003 Nov 4.

PMID:
14745596
5.

Upregulation of Epstein-Barr virus-encoded latent membrane protein by human herpesvirus 6 superinfection of EBV-carrying Burkitt lymphoma cells.

Cuomo L, Trivedi P, de Grazia U, Calogero A, D'Onofrio M, Yang W, Frati L, Faggioni A, Rymo L, Ragona G.

J Med Virol. 1998 Jul;55(3):219-26.

PMID:
9624610
6.

Treatment of Akata EBV-positive cells with doxorubicin causes more EBV reactivation than treatment with etoposide.

Lima RT, Seca H, Brás S, Nascimento MS, Vasconcelos MH.

Chemotherapy. 2011;57(3):195-203. doi: 10.1159/000323627. Epub 2011 Apr 29.

PMID:
21540588
7.

Expression of bcl-2 in Burkitt's lymphoma cell lines: induction by latent Epstein-Barr virus genes.

Finke J, Fritzen R, Ternes P, Trivedi P, Bross KJ, Lange W, Mertelsmann R, Dölken G.

Blood. 1992 Jul 15;80(2):459-69.

10.

Epstein-Barr virus-encoded Bcl-2 homologue functions as a survival factor in Wp-restricted Burkitt lymphoma cell line P3HR-1.

Watanabe A, Maruo S, Ito T, Ito M, Katsumura KR, Takada K.

J Virol. 2010 Mar;84(6):2893-901. doi: 10.1128/JVI.01616-09. Epub 2009 Dec 30.

11.

Selective efficacy of depsipeptide in a xenograft model of Epstein-Barr virus-positive lymphoproliferative disorder.

Roychowdhury S, Baiocchi RA, Vourganti S, Bhatt D, Blaser BW, Freud AG, Chou J, Chen CS, Xiao JJ, Parthun M, Chan KK, Eisenbeis CF, Ferketich AK, Grever MR, Chen CS, Caligiuri MA.

J Natl Cancer Inst. 2004 Oct 6;96(19):1447-57.

PMID:
15467034
13.

Epstein-Barr virus RNA confers resistance to interferon-alpha-induced apoptosis in Burkitt's lymphoma.

Nanbo A, Inoue K, Adachi-Takasawa K, Takada K.

EMBO J. 2002 Mar 1;21(5):954-65.

15.

Epstein-Barr virus-associated Burkitt lymphomagenesis selects for downregulation of the nuclear antigen EBNA2.

Kelly G, Bell A, Rickinson A.

Nat Med. 2002 Oct;8(10):1098-104. Epub 2002 Sep 3.

PMID:
12219084
16.
17.

Epstein-Barr virus infection and its gene expression in gastric lymphoma of mucosa-associated lymphoid tissue.

Xu WS, Chan AC, Lee JM, Liang RH, Ho FC, Srivastava G.

J Med Virol. 1998 Dec;56(4):342-50.

PMID:
9829640
18.

Epstein-barr virus regulates c-MYC, apoptosis, and tumorigenicity in Burkitt lymphoma.

Ruf IK, Rhyne PW, Yang H, Borza CM, Hutt-Fletcher LM, Cleveland JL, Sample JT.

Mol Cell Biol. 1999 Mar;19(3):1651-60.

19.

STAT6 signaling pathway activated by the cytokines IL-4 and IL-13 induces expression of the Epstein-Barr virus-encoded protein LMP-1 in absence of EBNA-2: implications for the type II EBV latent gene expression in Hodgkin lymphoma.

Kis LL, Gerasimcik N, Salamon D, Persson EK, Nagy N, Klein G, Severinson E, Klein E.

Blood. 2011 Jan 6;117(1):165-74. doi: 10.1182/blood-2010-01-265272. Epub 2010 Sep 27.

20.

Silencing of latent membrane protein 2B reduces susceptibility to activation of lytic Epstein-Barr virus in Burkitt's lymphoma Akata cells.

Rechsteiner MP, Berger C, Weber M, Sigrist JA, Nadal D, Bernasconi M.

J Gen Virol. 2007 May;88(Pt 5):1454-9.

PMID:
17412973

Supplemental Content

Support Center